₹3.30
(Market cap
₹445 Cr
Recently Viewed
Clear AllMarket cap
₹445 Cr
Revenue (TTM)
₹264 Cr
P/E Ratio
34.4
P/B Ratio
3.9
Div. Yield
0 %
Quality Score
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
₹13 Cr
ROE
34.9 %
ROCE
26.2 %
Industry P/E
30.1
EV/EBITDA
19
Debt to Equity
1.2
Book Value
₹27.8
EPS
₹7.3
Face value
10
Shares outstanding
23,405,000
CFO
₹--
EBITDA
₹--
Net Profit
₹--
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Mahamaya Lifesciences
| 3.1 | 38.8 | 15.4 | -- | -- | -- | -- |
|
BSE Commodities
| 5.1 | 15.1 | 5.2 | 14.0 | 18.0 | 13.5 | 16.0 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Mahamaya Lifesciences
|
190.3 | 445.4 | 264.2 | 12.9 | -- | 34.9 | 34.4 | 3.9 |
| 4,670.5 | 21,028.0 | 5,620.6 | 670.4 | 13.4 | 22.4 | 31.4 | 6.5 | |
| 259.3 | 3,356.5 | 500.5 | 13.2 | 5.5 | 1.9 | 254 | 4.8 | |
| 1,393.6 | 2,320.2 | 1,240.4 | 132.3 | 13.1 | 12.2 | 17.5 | 1.9 | |
| 1,062.2 | 4,786.9 | 1,978.5 | 265.0 | 16.3 | 18 | 18.1 | 3.0 | |
| 699.7 | 2,030.7 | 2,072.7 | 140.8 | 9.5 | 12.4 | 14.3 | 1.7 | |
| 154.2 | 3,602.8 | 1,424.9 | -44.7 | -1.1 | -13.7 | -- | 5.3 | |
| 256.5 | 4,987.2 | 2,871.0 | 167.0 | 7.8 | 11.7 | 29.9 | 2.4 | |
| 1,109.7 | 10,014.5 | 5,031.2 | 565.9 | 9.9 | 21.9 | 17.7 | 3.6 | |
| 434.7 | 21,732.8 | 3,234.0 | 531.4 | 18.3 | 17.8 | 40.9 | 6.6 |
No Review & Analysis are available.
--
Incorporated
2016
Chairman
--
Managing Director
Krishnamurthy Ganesan
Headquarters
New Delhi, Delhi
Website
Looking for more details about Mahamaya Lifesciences Ltd’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
The share price of Mahamaya Lifesciences Ltd is ₹190.30 (BSE) as of 24-Apr-2026 IST. Mahamaya Lifesciences Ltd has given a return of --% in the last 1 years.
The P/E ratio of Mahamaya Lifesciences Ltd is 34.41 times as on 24-Apr-2026, a 14 premium to its peers’ median range of 30.10 times.
The P/B ratio of Mahamaya Lifesciences Ltd is 3.92 times as on 24-Apr-2026, a 29 premium to its peers’ median range of 3.04 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
0.00
|
|
2024
|
0.00
|
0.00
|
|
2023
|
0.00
|
0.00
|
|
2022
|
0.00
|
0.00
|
|
2025
|
0.00
|
0.00
|
The 52-week high and low of Mahamaya Lifesciences Ltd are Rs 205.05 and Rs 111.00 as of 25-Apr-2026.
Mahamaya Lifesciences Ltd has a market capitalisation of ₹ 445 Cr as on 24-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Mahamaya Lifesciences Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.